Skip to main content
SpringerLink
Log in

Computed Tomography of HCC

  • Chapter
  • First Online:
Hepatocellular Carcinoma

Part of the book series: Current Clinical Oncology ((CCO))

  • 2025 Accesses

Abstract

Contrast-enhanced CT allows an accurate noninvasive diagnosis of Hepatocellular Carcinoma (HCC) nodules, and assessment of hepatic vascular anatomy and patency. The use of state-of-the-art equipment and of a tailored protocol is crucial. CT results help to detect and stage HCC, select the best treatment option, and evaluate response to therapy. In this chapter, the CT protocol for the cirrhotic liver, the CT features of HCC before and after treatment and of portal vein thrombosis will be described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bruix J, Sherman M. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2. doi:10.1002/hep.24199.

    Google Scholar 

  2. HRSA/OPTN data reports. http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/Policy_8.pdfOPTN. Published 31 Oct 2013.

  3. Bae KT. Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Radiology. 2010;256(1):32–61. doi:10.1148/radiol.10090908.

    Article  PubMed  Google Scholar 

  4. Iannaccone R, Laghi A, Catalano C, Rossi P, Mangiapane F, Murakami T, Hori M, Piacentini F, Nofroni I, Passariello R. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology. 2005;234(2):460–7.

    Article  PubMed  Google Scholar 

  5. LI-RADS algorithm, Atlas, and Lexicon. http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/LIRADS/lirads%20v20131%20w%20note.pdf.

  6. Gardeur D, Lautrou J, Millard JC, Berger N, Metzger J. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications. J Comput Assist Tomogr. 1980;4(2):178–85.

    Article  CAS  PubMed  Google Scholar 

  7. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. HumPathol. 1991;22(2):172–8.

    CAS  Google Scholar 

  8. Nishida N, Goel A. Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics. 2011;12(2):130–7. doi:10.2174/138920211795564359.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Nonomura A, Nakanuma Y. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol. 1999;172(4):969–76.

    Article  CAS  PubMed  Google Scholar 

  10. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Takashima T, Nakanuma Y, Unoura M, Kobayashi K, Izumi R, Ida M, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991;178(2):493–7.

    Article  CAS  PubMed  Google Scholar 

  11. Taguchi K, Asayama Y, Aishima S, Nishi H, Sugimachi K, Matsuura S, Terashi T, Yamanaka T, Shimada M, Sugimachi K, Tsuneyoshi M. Morphologic approach to hepatocellular carcinoma development in man: de novo or the so-called ‘dysplastic nodule-carcinoma’ sequence? Oncol Rep. 2002;9(4):737–43.

    Google Scholar 

  12. International Working Party Terminology of nodular hepatocellular lesions. Hepatology. 1995;22(3):983–93.

    Article  Google Scholar 

  13. Park YN, Kim MJ. Hepatocarcinogenesis: imaging-pathologic correlation. Abdom Imaging. 2011;36(3):232–43. doi:10.1007/s00261-011-9688-y.

    Article  PubMed  Google Scholar 

  14. Lim JH, Kim EY, Lee WJ, Lim HK, Do YS, Choo IW, Park CK. Regenerative nodules in liver cirrhosis: findings at CT during arterial portography and CT hepatic arteriography with histopathologic correlation. Radiology. 1999;210(2):451–8.

    Article  CAS  PubMed  Google Scholar 

  15. The International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. International consensus group for hepatocellular neoplasia. Hepatology. 2009;49(2):658–64. doi:10.1002/hep.22709.

  16. Park YN. Update on precursor and early lesions of hepatocellular carcinomas. Arch Pathol Lab Med. 2011;135(6):704–15. doi:10.1043/2010-0524-RA.1.

    PubMed  Google Scholar 

  17. Tajima T, Honda H, Taguchi K, Asayama Y, Kuroiwa T, Yoshimitsu K, Irie H, Aibe H, Shimada M, Masuda K. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol. 2002;178(4):885–97.

    Article  PubMed  Google Scholar 

  18. Sadek AG, Mitchell DG, Siegelman ES, Outwater EK, Matteuccí T, Hann HW. Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology. 1995;195(3):753–6.

    Article  CAS  PubMed  Google Scholar 

  19. Quiroga S, Sebastià C, Pallisa E, Castellà E, Pérez-Lafuente M, Alvarez-Castells A. Improved diagnosis of hepatic perfusion disorders: value of hepatic arterial phase imaging during helical CT. Radiographics. 2001; 21(1):65–81.

    Google Scholar 

  20. Liu YI, Shin LK, Jeffrey RB, Kamaya A. Quantitatively defining washout in hepatocellular carcinoma. AJR Am J Roentgenol. 2013;200(1):84–9. doi:10.2214/AJR.11.7171.

    Article  PubMed  Google Scholar 

  21. Furlan A, Marin D, Vanzulli A, Patera GP, Ronzoni A, Midiri M, Bazzocchi M, Lagalla R, Brancatelli G. Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout. Br J Radiol. 2011;84(1001):403–12. doi:10.1259/bjr/18329080.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, Duca P. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol. 2006;101(3):513–23.

    Article  CAS  PubMed  Google Scholar 

  23. Cruite I, Tang A, Sirlin CB. Imaging-based diagnostic systems for hepatocellular carcinoma. AJR Am J Roentgenol. 2013;201(1):41–55. doi:10.2214/AJR.13.10570.

    Article  PubMed  Google Scholar 

  24. Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology. 2014;273(1):30–50. doi:10.1148/radiol.14132362.

    Google Scholar 

  25. Iguchi T, Aishima S, Sanefuji K, Fujita N, Sugimachi K, Gion T, Taketomi A, Shirabe K, Maehara Y, Tsuneyoshi M. Both fibrous capsule formation and extracapsular penetration are powerful predictors of poor survival in human hepatocellular carcinoma: a histological assessment of 365 patients in Japan. Ann Surg Oncol. 2009;16(9):2539–46. doi: 10.1245/s10434-009-0453-1.

    Article  PubMed  Google Scholar 

  26. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology. 1992;183(3):819–25.

    Article  CAS  PubMed  Google Scholar 

  27. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, Kohno H, Nakamura T, Yukaya H. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105(2):488–94.

    Article  CAS  PubMed  Google Scholar 

  28. Wakasa K, Sakurai M, Kuroda C, Marukawa T, Monden M, Okamura J, Kurata A. Effect of transcatheter arterial embolization on the boundary architecture of hepatocellular carcinoma. Cancer. 1990;65(4):913–9.

    Article  CAS  PubMed  Google Scholar 

  29. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol. 2000;33(2):282–9.

    Article  CAS  PubMed  Google Scholar 

  30. Rimola J, Forner A, Tremosini S, Reig M, Vilana R, Bianchi L, Rodríguez-Lope C, Solé M, Ayuso C, Bruix J. Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol. 2012;56(6):1317–23. doi:10.1016/j.jhep.2012.01.004.

    Article  PubMed  Google Scholar 

  31. Ueda K, Matsui O, Kawamori Y, Nakanuma Y, Kadoya M, Yoshikawa J, Gabata T, Nonomura A, Takashima T. Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology. 1998;206(1):161–6.

    Article  CAS  PubMed  Google Scholar 

  32. Kita R, Sakamoto A, Nagata Y, Nishijima N, Ikeda A, Matsuo H, Okada M, Ashida S, Taniguchi T, Kimura T, Osaki Y. Visualization of blood drainage area from hypervascular hepatocellular carcinoma on ultrasonographic images during hepatic arteriogram: Comparison with depiction of drainage area on contrast-enhanced ultrasound. Hepatol Res. 2012;42(10):999–1007. doi:10.1111/j.1872-034X.2012.01019.x.

    Article  PubMed  Google Scholar 

  33. Kojiro M. Histopathology of liver cancers. Best Pract Res Clin Gastroenterol. 2005;19(1):39–62.

    Article  PubMed  Google Scholar 

  34. Reynolds AR, Furlan A, Fetzer DT, Sasatomi E, Borhani AA, Heller MT, Tublin ME. Infiltrative hepatocellular carcinoma: what radiologists need to know. Radiographics. 2015;35(2):371–86. doi:10.1148/rg.352140114.

    Google Scholar 

  35. Tublin ME, Dodd GD 3rd, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol. 1997;168(3):719–23.

    Article  CAS  PubMed  Google Scholar 

  36. Ito K, Higuchi M, Kada T, et al. CT of acquired abnormalities of the portal venous system. Radiographics. 1997;17(4):897–917.

    Google Scholar 

  37. Murray KF, Carithers RL Jr, AASLD. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 2005;41(6):1407–32.

    Google Scholar 

  38. Agnello F, Salvaggio G, Cabibbo G, Maida M, Lagalla R, Midiri M, Brancatelli G. Imaging appearance of treated hepatocellular carcinoma. World J Hepatol. 2013;5(8):417–24. doi:10.4254/wjh.v5.i8.417.

    Google Scholar 

  39. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52–60.

    Article  CAS  PubMed  Google Scholar 

  40. Sainani NI, Gervais DA, Mueller PR, Arellano RS. Imaging after percutaneous radiofrequency ablation of hepatic tumors: part 2, Abnormal findings. AJR Am J Roentgenol. 2013;200(1):194–204. doi:10.2214/AJR.12.8479.

    Article  PubMed  Google Scholar 

  41. Lu DS, Yu NC, Raman SS, Limanond P, Lassman C, Murray K, Tong MJ, Amado RG, Busuttil RW. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology. 2005;234(3):954–60.

    Article  PubMed  Google Scholar 

  42. Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V, Petrow P, Roche A, Sigal R. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223(1):255–62.

    Article  PubMed  Google Scholar 

  43. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer. 2000;88(11):2452–63.

    Article  CAS  PubMed  Google Scholar 

  44. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology. 1995;197(1):101–8.

    Article  CAS  PubMed  Google Scholar 

  45. Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009;104:514–24.

    Article  PubMed  Google Scholar 

  46. Oeda S, Mizuta T, Isoda H, Kuwashiro T, Iwane S, Takahashi H, Kawaguchi Y, Eguchi Y, Ozaki I, Tanaka K, et al. Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection. Hepatogastroenterology. 2013;60(126):1399–404.

    PubMed  Google Scholar 

  47. Lewandowski RJ, Geschwind JF, Liapi E, Salem R. Trans catheter intraarterial therapies: rationale and overview. Radiology. 2011;259(3):641–57. doi:10.1148/radiol.11081489.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Takayasu K, Arii S, Matsuo N, Yoshikawa M, Ryu M, Takasaki K, Sato M, Yamanaka N, Shimamura Y, Ohto M. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol. 2000;175(3):699–704.

    Article  CAS  PubMed  Google Scholar 

  49. Kim HC, Kim AY, Han JK, Chung JW, Lee JY, Park JH, Choi BI. Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images. Radiology. 2002;225(3):773–80.

    Article  PubMed  Google Scholar 

  50. Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa K, Iwanaga S, Mori M, Morikawa M, Fukuda T, Hayashi K, Matsunaga N. Complications associated with transcatheter arterial embolization of hepatic tumors. Radiographics. 1998;18(3):605–19.

    Google Scholar 

  51. Atassi B, Bangash AK, Bahrani A, Pizzi G, Lewandowski RJ, Ryu RK, Sato KT, Gates VL, Mulcahy MF, Kulik L, Miller F, Yaghmai V, Murthy R, Larson A, Omary RA, Salem R. Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics. 2008;28(1):81–99. doi:10.1148/rg.281065721.

    Google Scholar 

  52. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–90. doi:10.1056/NEJMoa0708857.

    Google Scholar 

  53. Salvaggio G, Furlan A, Agnello F, Cabibbo G, Marin D, Giannitrapani L, Genco C, Midiri M, Lagalla R, Brancatelli G. Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. Radiol Med. 2014;119(4):215–21. doi:10.1007/s11547-013-0332-5.

    Article  PubMed  Google Scholar 

  54. Ronot M, Bouattour M, Wassermann J, Bruno O, Dreyer C, Larroque B, Castera L, Vilgrain V, Belghiti J, Raymond E, Faivre S. Alternative response criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with Sorafenib. Oncologist. 2014;19(4):394–402. doi:10.1634/theoncologist.2013-0114.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sezione di Scienze Radiologiche, Università degli Studi di Palermo, Palermo, Italy

    Francesco Agnello & Giuseppe Brancatelli

Authors
  1. Francesco Agnello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Brancatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Brancatelli .

Editor information

Editors and Affiliations

  1. Dokuz Eylul University, Izmir Biomedicine and Genome Center Dokuz Eylul University, Izmir, Izmir, Turkey

    Brian I. Carr

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Agnello, F., Brancatelli, G. (2016). Computed Tomography of HCC. In: Carr, B. (eds) Hepatocellular Carcinoma. Current Clinical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-34214-6_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-34214-6_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-34212-2

  • Online ISBN: 978-3-319-34214-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation